Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism | Zendy

Bernhard Meier | Zendy; Bindu Kalesan | Zendy; Heinrich P. Mattle | Zendy; Ahmed A. Khattab | Zendy; David HildickSmith | Zendy; Dariusz Dudek | Zendy; Grethe Andersen | Zendy; Réda Ibrahim | Zendy; Gerhard Schüler | Zendy; Antony Walton | Zendy; Andreas Wahl | Zendy; Stephan Windecker | Zendy; Peter Jüni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism

Author(s) -

Bernhard Meier,

Bindu Kalesan,

Heinrich P. Mattle,

Ahmed A. Khattab,

David HildickSmith,

Dariusz Dudek,

Grethe Andersen,

Réda Ibrahim,

Gerhard Schüler,

Antony Walton,

Andreas Wahl,

Stephan Windecker,

Peter Jüni

Publication year - 2013

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1211716

Subject(s) - medicine , patent foramen ovale , hazard ratio , percutaneous , stroke (engine) , surgery , confidence interval , embolism , paradoxical embolism , cardiology , mechanical engineering , engineering

The options for secondary prevention of cryptogenic embolism in patients with patent foramen ovale are administration of antithrombotic medications or percutaneous closure of the patent foramen ovale. We investigated whether closure is superior to medical therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research